Recent Updates
Recently added Catalysts
SIBN Positive Sentiment Score: 70/100

SI-BONE To Present at BofA Securities 2026 Healthcare Conference on May 12, 2026

Key Takeaway: SI-BONE, Inc. will participate in the 2026 BofA Securities Healthcare Conference in Las Vegas on May 12, 2026. The company will host a fireside chat to discuss its procedural solutions for compromised bone. Investors can register for the event and access a live audio webcast on the company's website.

Market Sentiment Analysis

POSITIVE FACTORS

  • SI-BONE is a leader in developing solutions for compromised bone.
  • The company has a strong track record with over 140,000 procedures performed.
  • Management will engage with investors at a prominent healthcare conference.

Full Press Release Details

SANTA CLARA, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced that the company will be participating in the upcoming 2026 BofA Securities Healthcare Conference in Las Vegas, NV. Management will be hosting a fireside chat on Tuesday, May 12, 2026, at 8:00 a.m. Pacific Time/11:00 a.m. Eastern Time.
Investors interested in listening to the conference call may do so by registering at this link:https://bofa.veracast.com/webcasts/bofa/healthcare2026/f3F578.cfm. Live audio of the webcast will be available on the “Investors” section of the company’s website at:www.si-bone.com. The webcast will be archived and available for replay for at least 90 days after the event.

About SI-BONE, Inc.

SI-BONE (NASDAQ: SIBN) is a global leader in developing procedural solutions to address clinical challenges associated with compromised bone. With expertise in biomechanical design and anatomy specific innovation, SI-BONE has built a technology platform with market-leading applications centered on the spinopelvic anatomy. SI-BONE continues to leverage the deep experience in addressing the challenges of low-density bone in the sacrum to develop unique technologies that are targeting new clinical adjacencies to help improve outcomes for patients with compromised bone. Since 2009, SI-BONE has supported physicians in performing a total of over 140,000 procedures. A unique body of clinical evidence supports the use of SI-BONE's technologies, including four randomized controlled trials and over 180 peer reviewed publications.
For additional information on the company or the products, including risks and benefits, please visitwww.si-bone.com.
SI-BONE® is a registered trademark of SI-BONE, Inc. ©2026 SI-BONE, Inc. All Rights Reserved.

Investor Contact

Saqib IqbalVP, FP&A and Investor Relationsinvestors@SI-BONE.com

Frequently Asked Questions

When will SI-BONE present at the BofA Securities Conference?

SI-BONE will present on May 12, 2026, at 8:00 a.m. Pacific Time.

How can investors listen to the conference call?

Investors can register for the conference call via the provided link on SI-BONE's website.

What is SI-BONE known for?

SI-BONE specializes in developing solutions for clinical challenges related to compromised bone.

How many procedures has SI-BONE supported?

SI-BONE has supported over 140,000 procedures since its inception.

Last updated: Apr 30, 2026